Mounjaro (Tirzepatide) – Injectable for Weight Loss In Malaysia
Mounjaro is a once-weekly injectable medication for managing type 2 diabetes and promoting weight loss through dual GIP and GLP-1 receptor agonist activity.
- The description claims clinically proven enhanced weight reduction.
- The description claims the need for doctor supervision.
Specifications
- Strength
- 2.5mg Pen, 5mg Pen, 7.5mg Pen, 10mg Pen
Variants (4)
- 2.5mg Pen — 1150.00 MYR — In stock
- 5mg Pen — 1500.00 MYR — In stock
- 7.5mg Pen — 1950.00 MYR — In stock
- 10mg Pen — 2200.00 MYR — In stock
AI Readiness
Good foundation, but some important product data is still missing.
66%